The global nucleic acid isolation and purification market are expected to witness a CAGR of 9.1% during the forecast period. The nucleic acid isolation and purification market have gained substantial traction as it is widely adopted in medical applications like research, drug discovery, etc. There is increased demand for high-quality pure nucleic acid like DNA and RNA for genetic analysis and medical, scientific, and forensic purposes. Moreover, the rising demand from pharmaceutical and biotechnology industries, employed in the test for diagnosis, development of genotyping, molecular diagnostics, and expression analysis will drive the growth of the market. Nevertheless, technological development, enhanced regulatory and reimbursement scenarios, personalized medicine, and untapped potential in emerging economies will create promising opportunities for growth in the nucleic acid isolation and purification market.

In September 2021, Thermo Fisher Scientific announced that it would manufacture a prefilled MagMax Dx kit for the isolation of viral/pathogenic nucleic acids in India for the Indian market so as to isolate and purify RNA and DNA from human saliva nasopharyngeal and oropharyngeal swabs to provide a faster, accurate and easy to use solution for customers.

Request to get a free sample copy at https://www.vynzresearch.com/healthcare/nucleic-acid-isolation-and-purification-market/request-sample

The COVID19 crisis serves as a positive catalyst for the growth of the nucleic acid isolation and purification market. Various researchers and companies globally are concentrating on evolving specific assays and kits for the rapid detection of SARSCoV2. For example, Omega Biotek, Inc. Has launched the MagBind Viral RNA Xpress Kit for effective and rapid isolation of viral RNA and the company declared a monthly capacity of 6 million tests, resulting in a dramatic increase in capacity.

Based upon method, the nucleic acid isolation and purification market is categorized into column-based, magnetic bead-based, reagent-based, and others. The column-based method dominates the market as these can be incorporated in microchips and spin columns as it offers benefits like being cost-effective, providing fast organic extraction, and being compatible with automated instruments.

Asia-Pacific is anticipated to be the fastest-growing region owing to the rising number of genomic projects and mounting R&D investments in pharmaceutical and biotechnology companies that will drive the growth of the region.

Some of the major players in the global Nucleic Acid Isolation and Purification market include Thermo Fisher Scientific, F. Hoffman-La Roche, Danaher Corporation, Qiagen N.V., Illumina, Agilent Technologies, Merck KGaA, Promega Corporation, Bio-Rad Laboratories and GE Healthcare.

Source VynZ Research